|
| CXCL13/CXCR6信号通路
在HBV感染中的研究进展及临床意义 |
| Progress and clinical significance of CXCL13/CXCR6 signaling pathway in HBV infection |
| |
| DOI：10.3969/j.issn.1007-8134.2022.04.002 |
| 中文关键词: 趋化因子配体13 趋化因子受体5 乙型肝炎病毒 感染 免疫应答 体液免疫 细胞免疫 临床治愈 |
| 英文关键词: CXCL13 CXCR5 HBV infection immune response humoral immunity cellular immunity clinical cure |
| 基金项目:国家自然科学基金创新群体项目（81721003） |
|
| 摘要点击次数: 273 |
| 全文下载次数: 280 |
| 中文摘要: |
| [摘要]?HBV感染是人类面临的重大公共卫生问题，尽管有效的抗病毒治疗可延缓疾病进展，但仍很难实现“临床治愈”的目标。机体的适应性免疫应答在控制和清除病毒的过程中发挥关键作用。新近研究发现，趋化因子配体13（chemokine ligand 13, CXCL13）/趋化因子受体5（chemokine receptor 5, CXCR5）信号通路在调节HBV特异性体液免疫和细胞免疫应答中均发挥重要作用，这或是探索慢性乙型肝炎“临床治愈”的重要靶点。本文就CXCL13/CXCR5信号通路的生物学特点及其在HBV感染中的临床研究进展及意义进行综述。 |
| 英文摘要: |
| [Abstract] HBV infection is a major public health problem affecting the world. Though effective antiviral therapy can delay disease progression, achieving a “clinical cure” is still difficult. The adaptive immune response plays a key role in controlling and eliminating the virus. Recently, some studies have found that the chemokine ligand 13 (CXCL13) and its receptor chemokine receptor 5 (CXCR5) signaling pathway plays an important role in the regulation of HBV-specific humoral and cellular immune response, which may be an important target for exploring the “clinical cure” of chronic hepatitis B. In this paper, we summarized the biological characteristics of CXCL13/CXCR5 signaling pathway and its clinical research progress and significance in HBV infection. |
|
HTML
查看全文
下载PDF阅读器 |
| 关闭 |